online pharmacy, prescription drugs online



Drugs online research references









  • Angiotensin(1-7) in the spontaneously hypertensive rat.
  • Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
  • Frequency of cough during therapy with ACE inhibitors in Greek hypertensives.
  • Role of ACE in the gastric cytoprotection. Dopaminergic and peripheral alpha 2 adrenergic mechanisms
  • Use and abuse of clinical trials. Is the timing of treatment critical?
  • Correlation of left ventricular hypertrophy and its regression by lisinopril with salt-induced hypertension.
  • Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
  • Treatment of hypertension with lisinopril in end-stage renal failure.
  • Enzymatic properties of dipeptidyl carboxypeptidase from Bacillus pumilus.
  • Enalapril to lisinopril: economic impact of a voluntary angiotensin-converting enzyme-inhibitor substitution program in a staff-model health maintenance organization.
  • In Process Citation
  • Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine.
  • Effects of lisinopril on electromechanical properties and membrane currents in guinea-pig cardiac preparations.
  • ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin.
  • Angiotensin converting enzyme in the monkey (Macaca fascicularis) brain visualized by in vitro autoradiography.
  • Angiotensin-converting enzyme in the rabbit stomach wall. Identification in the membrane fraction by affinity purification.
  • Angiotensin converting enzyme: substrate inhibition.
  • Angiotensin-converting enzyme from human tissues. Physicochemical, catalytic, and immunological properties.
  • Production of renin, angiotensin II, and aldosterone by adrenal explant cultures: response to potassium and converting enzyme inhibition.
  • Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P.
  • Pulse wave velocity as expression of arterial compliance and its importance in the evaluation of arterial hypertension
  • Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction.
  • A peptidyl dipeptidase-4 from Pseudomonas maltophilia: purification and properties.
  • Comparative renal hemodynamic effects of lisinopril, verapamil, and amlodipine in patients with chronic renal failure.
  • Lisinopril treatment of hypertension in patients with impaired renal function.
  • Lung MK 351A uptake after hypoxia adaptation and subsequent hyperoxia exposure.
  • Nitric oxide participation in renal hemodynamic effect of angiotensin converting enzyme inhibitor lisinopril.
  • Increase in vasoactive intestinal polypeptides (VIP) by the angiotensin converting enzyme (ACE) inhibitor lisinopril in congestive heart failure. Relation to haemodynamic and hormonal changes.
  • Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases.
  • Long-term monotherapy with lisinopril in renovascular hypertension.
  • Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells.
  • Pharmacokinetics of lisinopril.
  • Inhibition study of angiotensin converting enzyme by capillary electrophoresis after enzymatic reaction at capillary inlet.
  • Rat intestinal angiotensin-converting enzyme: purification, properties, expression, and function.
  • Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
  • Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
  • Localization of angiotensin-converting enzyme in the trout gill.
  • Isolation of a neuropeptide-degrading carboxypeptidase from the human stomach.
  • Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension.
  • Transcriptional activation of low density lipoprotein receptor gene by angiotensin-converting enzyme inhibitors and Ca(2+)-channel blockers involves protein kinase C isoforms.
  • Population pharmacokinetics of lisinopril in hypertensive patients.
  • Lisinopril in the treatment of hypertension: a Canadian postmarketing surveillance study.
  • Lisinopril in elderly patients with hypertension.
  • Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting.
  • A study of the potential pharmacokinetic interaction of lisinopril and digoxin in normal volunteers.
  • Mediation of humoral catecholamine secretion by the renin-angiotensin system in hypotensive rainbow trout (Oncorhynchus mykiss).
  • Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats.
  • Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate.
  • Differential response of angiotensin peptides in the urine of hypertensive animals.
  • Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses.
  • Converting enzyme inhibitors in acute myocardial infarct and heart failure
  • Internally quenched fluorogenic substrates for angiotensin I-converting enzyme.
  • Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression.
  • Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat.
  • Recommendations for the management of special populations: racial and ethnic populations.
  • Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
  • Local generation of angiotensin II as a mechanism of aldosterone secretion in rat adrenal capsules.
  • Plasma levels of nitric oxide and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension.
  • The incidence of active duty dental patients taking antihypertensive medications.
  • No expression of angiotensin II receptors and angiotensin-converting enzyme in myxomatous canine mitral valve leaflets. An autoradiographic study.
  • Fas-induced apoptosis of alveolar epithelial cells requires ANG II generation and receptor interaction.
  • Effects of angiotensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages.
  • Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine.
  • ACE Inhibitors and Renal Vascular Responses in the Spontaneously Hypertensive Rat.
  • Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
  • The state of hemodynamics and microcirculation in patients with hypertensive disease during long term controlled therapy with lisinopril
  • Effects of lisinopril on experimental ischemia in rats. Influence of infarct size.
  • Stimulation of bradykinin B(1) receptors induces vasodilation in conductance and resistance coronary vessels in conscious dogs: comparison with B(2) receptor stimulation.
  • Purification and characterization of a dipeptidyl carboxypeptidase from the polychaete Neanthes virens resembling angiotensin I converting enzyme.
  • Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics
  • Benidipine inhibits apoptosis during ischaemic acute renal failure in rats.
  • Reversal of heart failure remodeling in women.
  • Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
  • Effects of angiotensin-converting enzyme inhibitors and sclerotherapy on portal hemodynamics in patients with portal hypertension.
  • The role of plasminogen activation in smooth muscle cell migration after arterial injury.
  • Exclusion of angiotensin I-converting enzyme as a candidate gene involved in exudative inflammatory resistance in F344/N rats.
  • Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients.
  • Poor regression of myocardial hypertrophy following concomitant chronic alcohol ingestion and angiotensin converting enzyme (ACE) inhibition.
  • Effectiveness of Lisinopril in the treatment of heart failure
  • Pathways for angiotensin-(1---7) metabolism in pulmonary and renal tissues.
  • Vascular catabolism of bradykinin in the isolated perfused rat kidney.
  • In vitro degradation of the Neb-Trypsin modulating oostatic factor (Neb-TMOF) in gut luminal content and hemolymph of the grey fleshfly, Neobellieria bullata.
  • Retinal neovascularization is prevented by blockade of the renin-angiotensin system.
  • Combination therapy with angiotensin converting enzyme inhibition and AT1 receptor inhibitor on ventricular remodeling after myocardial infarction in rats.
  • In vivo protein synthetic rates of atrial, ventricular, and pulmonary tissue proteins in aortic constriction, goldblatt, and bromoethylamine models of hypertension.
  • Expression of Ca(2+) Transport Genes in Platelets and Endothelial Cells in Hypertension.
  • Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation.
  • Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion.
  • Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.
  • Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF.
  • ACE inhibitors and vagal activity: the effect of captopril and lisinopril on cardiovascular reflexes
  • Neurovascular interactions between aldose reductase and angiotensin-converting enzyme inhibition in diabetic rats.
  • Rx drugs
  • Characterization of bovine atrial angiotensin-converting enzyme.
  • Influences of different antihypertensive treatments on indices of systemic mineral metabolism.
  • Effects of various antihypertensive drugs on the function of osteoblast.
  • The influence of the ACE inhibitor lisinopril on the glomerular metabolism of proteolytic enzymes in diabetic rats.
  • The effects of C-type natriuretic peptide on catecholamine release in the pacific spiny dogfish (Squalus acanthias).
  • Glomerular injury induced by hydrogen peroxide: modifying influence of ACE inhibitors.
  • Changes in cardiac renin-angiotensin system after severe burn injury in rats
  • Norepinephrine induces alveolar epithelial apoptosis mediated by alpha-, beta-, and angiotensin receptor activation.
  • Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs.
  • Anti-fibrogenic effect of an angiotensin converting enzyme inhibitor on chronic carbon tetrachloride-induced hepatic fibrosis in rats.
  • Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.
  • Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
  • Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
  • Omapatrilat for the management of heart failure and hypertension.
  • The role of angiotensin II in regulating catecholamine secretion during hypoxia in rainbow trout Oncorhynchus mykiss.
  • Comparison of antihypertensive therapies by noninvasive techniques.
  • Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection.
  • Characterisation of 3Hceranapril recognition sites in rat and human brain tissue.
  • Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
  • Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
  • Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts.
  • Do severe systemic sequelae of proteinuria modulate the antiproteinuric response to chronic ACE inhibition?
  • Studies on the signal cascade mechanism mediating the cardioprotective actions of bradykinin.
  • Spectrophotometric determination of lisinopril in tablets using 1-fluoro-2,4-dinitrobenzene reagent.
  • Comparative effects of telmisartan in the treatment of hypertension.
  • Effect of angiotensin-converting enzyme inhibitors on liver regeneration in rats.
  • Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries.
  • Captopril and quinapril reduce reactive oxygen species.
  • Relative lipophilicities and structural-pharmacological considerations of various angiotensin-converting enzyme (ACE) inhibitors.
  • Relation of renin-angiotensin system gene polymorphisms and expressions with the efficacy of antihypertensive drugs.
  • Rx drugs
  • Rx drugs
  • Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril to rats.
  • The renin-angiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies.
  • Comparison of the cardiovascular protection by omapatrilat and lisinopril treatments in DOCA-salt hypertension.
  • Tissue kallikrein is synthesized and secreted by human vascular endothelial cells.
  • Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.
  • Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
  • Clinical study of the month. Which initial antihypertensive? Results from the ALLHAT trial
  • The Effect of Acute Angiotensin Converting Enzyme (ACE) and Neutral Endopeptidase 24.11 (NEP) Inhibition on Plasma Extravasation in the Rat.
  • Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats.
  • Purification and analysis of lung and plasma angiotensin I-converting enzyme by high-performance liquid chromatography.
  • Regulation of beta-adrenergic receptors on endothelial cells in culture.
  • Antihypertensive efficacy of lisinopril. Ambulatory blood pressure monitoring.
  • Effects of lisinopril, a new angiotensin converting enzyme inhibitor in a cryo-injury model of chronic left ventricular failure.
  • Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction.
  • Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
  • Endothelium-mediated vasodilation during ACE inhibition.
  • Effects of an early treatment with lisinopril and isosorbide-5-mononitrate on hemodynamics and late ventricular remodelling in rats with 9-week myocardial infarction.
  • Administration of maximal or median doses of drugs in cardiovascular diseases?
  • Tissue angiotensin I-converting enzyme activity in aging hamsters with and without cardiomyopathy.
  • Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow.
  • Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist.
  • Contribution of systemic blood pressure to myocardial remodeling in uremic rats.
  • Angioneurotic edema caused by angiotensin-converting enzyme inhibitors
  • Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.
  • Vascular compliance and mean circulatory filling pressure in trout: effects of ACE inhibition.
  • Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.
  • Angiotensin II receptor binding following myocardial infarction in the rat.
  • Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations.
  • Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat.
  • Distribution and characterization of angiotensin-converting enzyme-like activity in tissues of the blue crab Callinectes sapidus.
  • Naturally occurring active N-domain of human angiotensin I-converting enzyme.
  • Effects of lisinopril upon cardiac hypertrophy, central and peripheral hemodynamics and neurohumoral factors in spontaneously hypertensive rats.
  • Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
  • Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11) in cultured human endothelial cells.
  • Effects of lisinopril and captopril on calcium in rat heart.
  • A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries.
  • Purification and characterisation of swine serum proteinase which hydrolyses epidermal inhibitory pentapeptide.
  • The antihypertensive effect of lisinopril in a single daily dosage. A study of arterial pressure with ambulatory monitoring
  • Effects of lisinopril on the structure of renal arterioles.
  • Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE.
  • Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
  • Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
  • Time-resolved fluoroimmunoassay for the determination of lisinopril and enalaprilat in human serum.
  • Biochemical properties of the angiotensin-converting-like enzyme from the leech Theromyzon tessulatum.
  • Pharmacokinetic-pharmacodynamic model relating lisinopril plasma concentrations to regional hemodynamic effects in healthy volunteers.
  • Lifelong angiotensin-converting enzyme inhibition, pressure natriuresis, and renin-angiotensin system gene expression in transgenic (mRen-2)27 rats.
  • Localization and characterization of angiotensin II receptor binding and angiotensin converting enzyme in the human medulla oblongata.
  • Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects.
  • The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
  • Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
  • Effects of two inhibitors of renin-angiotensin system on attenuation of postoperative remodeling after left ventricular aneurysm repair in rats.
  • Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril.
  • Effect of angiotensin-converting enzyme inhibitors on fructose induced hypertension and hyperinsulinaemia in rats.
  • Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma.
  • Involvement of 5-hydroxytryptamine and bradykinin in the hyperalgesia induced in rats by collagenase from Clostridium histolyticum.
  • Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
  • Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats.
  • Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
  • Effects of lisinopril on intercellular resistance of guinea pig ventricular myocytes.
  • ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.
  • Fibrous tissue and angiotensin II.
  • Effect of ACE inhibitors on atrial natriuretic factor in the brains of rats with reduced renal mass.
  • Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo.
  • Comparison of the cardiac and hemodynamic effects of lisinopril and atenolol in patients with hypertension: therapeutic implications.
  • Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinopril.
  • Sheep testicular and epididymal angiotensin converting enzyme: inhibitions by captopril, lisinopril and enalapril.
  • A comparison of the zinc contents and substrate specificities of the endothelial and testicular forms of porcine angiotensin converting enzyme and the preparation of isoenzyme-specific antisera.
  • Prejunctional modulation by angiotensins of noradrenaline release from sympathetic neurons in isolated rabbit aorta.
  • Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan.
  • Presence of angiotensin converting enzyme in the adventitia of large blood vessels.
  • Calorimetric analysis of lisinopril binding to angiotensin I-converting enzyme.
  • Blockade of angiotensin converting enzyme in circumventricular organs of the brain after oral lisinopril administration demonstrated by quantitative in vitro autoradiography.
  • Renal nerve activity in rats with spontaneous hypertension: effect of converting enzyme inhibitor.
  • Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
  • Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart.
  • Significant role of the increase in renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in double transgenic tsukuba hypertensive mice carrying both human renin and angiotensinogen genes.
  • Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.
  • Hospital intensive monitoring of adverse reactions of ACE inhibitors
  • Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats.
  • Abnormalities of the extracellular degradation of collagen type I in essential hypertension.
  • Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo.
  • Effects of angiotensin II and angiotensin converting enzyme inhibitors on contractile and growth responses in isolated carotid arteries of the rat.
  • Functional role of chymase in angiotensin II formation in human vascular tissue.
  • Converting-enzyme inhibitors increase converting-enzyme mRNA and activity in endothelial cells.
  • Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension.
  • Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice.
  • Effect of frequently prescribed cardiovascular medications on sexual function: a pilot study.
  • Lisinopril and ramiprilat protection of the vascular endothelium against free radical-induced functional injury.
  • Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure.
  • Regulation of renin-angiotensin system in unilateral ureteral obstruction.
  • Manipulations of the renin-angiotensin system and intake of a sweetened alcoholic beverage among rats.
  • Enhanced blood pressure and renal hemodynamic effect of chronic versus acute lisinopril administration in the rabbit.
  • Effect of an angiotensin II receptor antagonist, TCV-116, on rat carotid artery neointimal formation after balloon injury.
  • Plasma concentrations of some cardiovascular humoral factors in essential hypertension and their changes during the treatment with converting enzyme inhibitor lisinopril.
  • Lisinopril in hypertension associated with renal impairment.







    online pharmacies || Hair Million herbal formula for hair loss and hair growth || Amoxicillin || Tramadol || Paxil || Rx Drugs USA, Prescription Drugs Online Pharmacy || Zithromax || online pharmacy || Antibiotics and prescription medications online literature || Antibiotics